Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - NET INCOME
Net Income LRMR - Larimar Therapeutics, Inc.
-36.9 M
LAST VALUE
14.58%
2 YEAR CAGR
9.65%
5 YEAR CAGR
-10.17%
10 YEAR CAGR